A single application of a "smart" self-repairing coating is being developed to dramatically extend rust protection for ...
NANJING, China, Aug. 28, 2026 /PRNewswire/ -- InxMed Co., Ltd ("InxMed"), a clinical-stage biotechnology company dedicated to developing innovative therapies targeting cancer treatment resistance and ...
Freenome has partnered with Abbott to commercialize the test, which is expected to be available in the US this fall. The Food and Drug Administration (FDA) has approved Freenome’s SimpleScreen ™ CRC, ...
As Bristol Myers Squibb attempts to convert two accelerated oncology nods for Krazati into traditional FDA approvals, the company has detailed a phase 3 flop in the KRAS G12C inhibitor’s ...
KRAS G12C occurs in ~3%–4% of CRC, translating to a sizable metastatic population with limited options and strong rationale for KRAS G12C inhibition strategies. Dual KRAS–EGFR blockade leverages ...
CHICAGO -- Patients who skipped maintenance therapy after a complete response to upfront treatment with a PD-1 inhibitor lived just as long as those who had 3 years of maintenance, data from a cohort ...
Cellular consequences of a germline SMC5 variant enriched in medulloblastoma. Re-sensitizing PD-1/PD-L1 relapsed/refractory solid tumors: Phase 1a results of IOS-1002, a LILRB1/2 and KIR3DL1 ...
Genomic profiling is crucial in metastatic colorectal cancer (CRC) management: RAS and BRAF alterations govern prognosis and eligibility for targeted therapies. The expanding landscape of RAS directed ...
A recent study published in Engineering has shed light on a novel therapeutic target for improving anti-angiogenic treatment in colorectal cancer (CRC). The research, conducted by an international ...
As winter comes to an end, many drivers turn their attention to the usual spring rituals: washing off months of grime, swapping winter tires, and giving their cars a long-overdue deep clean. We've ...
Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. The great news in CRC these days, finally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results